Comvita Limited (NZE:CVT)
New Zealand
· Delayed Price · Currency is NZD | Market Cap | 50.10M |
| Revenue (ttm) | 210.69M |
| Net Income (ttm) | -93.69M |
| Shares Out | 70.56M |
| EPS (ttm) | -1.33 |
| PE Ratio | n/a |
| Forward PE | 7.81 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,870 |
| Average Volume | 23,695 |
| Open | 0.710 |
| Previous Close | 0.715 |
| Day's Range | 0.710 - 0.710 |
| 52-Week Range | 0.430 - 0.795 |
| Beta | 0.35 |
| RSI | 61.77 |
| Earnings Date | Feb 19, 2026 |
About Comvita
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities. The company sells its products online through i... [Read more]
Financial Performance
In fiscal year 2025, Comvita's revenue was 192.43 million, a decrease of -4.11% compared to the previous year's 200.68 million. Losses were -104.76 million, 30.3% more than in 2024.
Financial StatementsNews
Comvita Limited (CVNZF) Q2 2026 Earnings Call Transcript
Comvita Limited (CVNZF) Q2 2026 Earnings Call Transcript
Comvita Limited (CVNZF) Shareholder/Analyst Call Transcript
Comvita Limited (CVNZF) Shareholder/Analyst Call Transcript